GLP-1 Pill Rybelsus approved for Type 2
24/04/2020
No Comments
The first GLP-1 agonist pill for Type 2 diabetes has been approved by the European Medicines Agency (EMA). Rybelsus (known as oral semaglutide in clinical trials) is a once-daily
